Skip to main content
21 January 2021
Last updated:
Thursday 21 January 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

MorphoSys appoints new CFO

Thursday 7 January 2021
Company
MorphoSys AG
Appointee Name
Sung 
Lee
Country

Germany

MorphoSys AG has appointed Sung Lee as chief financial officer effective 2 February as it commercialises its first oncology product on the US market. Mr Lee joins from Sangamo Therapeutics Inc where he was CFO. Prior to this, he led global financial planning and analysis at Gilead Sciences Inc. Mr Lee received a master of business taxation from the University of Southern California and a degree in economics from the University of California, Irvine, US.

MorphoSys announced the appointment on 6 January 2021.

Copyright 2021 Evernow Publishing Ltd

 

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

T-knife appoints Thomas Soloway as chief executive
Thursday January 21 2021
Domainex makes two executive appointments
Thursday January 21 2021
Richard Francis named CEO of Purespring
Tuesday January 19 2021
Klaas Zuideveld becomes CEO of Versameb
Saturday January 16 2021
MorphoSys appoints new CFO
Thursday January 7 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.